药品
医学
疾病
精神分裂症(面向对象编程)
重症监护医学
精神科
内科学
作者
Daniel A. Hussar,Laura A. Finn
出处
期刊:The Senior care pharmacist
[American Society of Consultant Pharmacists]
日期:2021-04-01
卷期号:36 (4): 176-186
标识
DOI:10.4140/tcp.n.2021.176
摘要
Five new drugs marketed within the last year that are used for medical problems often experienced by older people have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author (DAH). Advantages, disadvantages, and other important information regarding each new drug are identified and used as the basis for determining the rating. The drugs considered include new agents indicated for the treatment of patients with hypercholesterolemia, Parkinson’s disease, insomnia, schizophrenia, and age-related macular degeneration.
科研通智能强力驱动
Strongly Powered by AbleSci AI